158 related articles for article (PubMed ID: 15225176)
1. Seven-day therapy for Helicobacter pylori in the United States.
Vakil N; Lanza F; Schwartz H; Barth J
Aliment Pharmacol Ther; 2004 Jul; 20(1):99-107. PubMed ID: 15225176
[TBL] [Abstract][Full Text] [Related]
2. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Lüth S; Teyssen S; Kölbel CB; Singer MV
Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
[TBL] [Abstract][Full Text] [Related]
4. Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
Calvet X; Ducons J; Bujanda L; Bory F; Montserrat A; Gisbert JP;
Am J Gastroenterol; 2005 Aug; 100(8):1696-701. PubMed ID: 16086704
[TBL] [Abstract][Full Text] [Related]
5. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
[TBL] [Abstract][Full Text] [Related]
7. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
Zullo A; Gatta L; De Francesco V; Hassan C; Ricci C; Bernabucci V; Cavina M; Ierardi E; Morini S; Vaira D
Aliment Pharmacol Ther; 2005 Jun; 21(12):1419-24. PubMed ID: 15948808
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J; Inamori M; Fujisawa N; Takahashi H; Yoneda M; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
Hepatogastroenterology; 2005; 52(62):645-8. PubMed ID: 15816496
[TBL] [Abstract][Full Text] [Related]
9. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
[TBL] [Abstract][Full Text] [Related]
10. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
Laine L; Suchower L; Frantz J; Connors A; Neil G
Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
[TBL] [Abstract][Full Text] [Related]
11. Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication: 7 vs. 14 day treatment.
Bosques-Padilla FJ; Garza-González E; Calderón-Lozano IE; Reed-SanRoman G; de Ariño Suárez M; Valdovinos-Díaz MA; Orozco-Gámiz A; Blancas-Valencia JM; Tamayo-de la Cuesta JL
Helicobacter; 2004 Oct; 9(5):417-21. PubMed ID: 15361080
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.
Sharara AI; Chaar HF; Racoubian E; Moukhachen O; Barada KA; Mourad FH; Araj GF
Helicobacter; 2004 Jun; 9(3):255-61. PubMed ID: 15165262
[TBL] [Abstract][Full Text] [Related]
13. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Lamouliatte H; Cayla R; Zerbib F; Forestier S; de Mascarel A; Joubert-Collin M; Mégraud F
Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
[TBL] [Abstract][Full Text] [Related]
14. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
Nista EC; Candelli M; Cremonini F; Cazzato IA; Zocco MA; Franceschi F; Cammarota G; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1181-8. PubMed ID: 15569121
[TBL] [Abstract][Full Text] [Related]
15. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E
Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942
[TBL] [Abstract][Full Text] [Related]
16. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Fujioka T; Kodama M; Abe T; Sato S; Arita T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):262-7. PubMed ID: 16460484
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
Hassan C; De Francesco V; Zullo A; Scaccianoce G; Piglionica D; Ierardi E; Panella C; Morini S
Aliment Pharmacol Ther; 2003 Sep; 18(6):641-6. PubMed ID: 12969091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
